Clinical Trial Update: Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication

View source ↗

Summary

Completed clinical trial evaluating programming of implantable cardioverter-defibrillators for patients with a primary prevention indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure
• Ischemic Heart Disease

Snippet

Sponsor: Abbott Medical Devices | Conditions: Shock | Status: COMPLETED